As clinical development becomes increasingly complex and costly, biotech and pharmaceutical companies are rethinking how they partner with contract research organizations (CROs) to harmonize speed, ...
New drug development is a race against the clock as soon as the first patents are filed, and understanding the potential timings from first-in-human studies to regulatory approval is crucial for ...
BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced new capabilities ...
Company remains on track for anticipated IND filing in Q3 2026, marking a transformative step toward becoming a ...
When it comes to developing new drugs, one of the most time-consuming and complex pieces of the puzzle is the task of compiling all of the data collected throughout the clinical development process to ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Outsourcing of non-core services and resources is common practice in today’s world as companies look to reduce overhead and costs and streamline their businesses. Pharmaceutical companies outsource ...
The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...
These projects are not only about adding beds or buildings; they represent a broader effort to bring advanced care, clinical research and new treatments closer to home.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results